Malin Corporation reported EUR62.1M in Cash and Equivalent for its fiscal semester ending in December of 2024.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
ALKERMES USD 521.2M 121.39M Jun/2025
Avita Medical AUD 14.05M 3.4M Dec/2024
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Eurofins Scientific SE EUR 613.9M 67.3M Dec/2024
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 1.28B 344M Jun/2025
Organon & Co USD 599M 52M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Viatris USD 566.4M 188.6M Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025